Order Article Reprints

Minosse C, Gruber CEM, Rueca M, Taibi C, Zaccarelli M, Grilli E, Montalbano M, Capobianchi MR, Antinori A, D’Offizi G, et al. Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs. Viruses. 2021; 13(6):1151. https://doi.org/10.3390/v13061151

Minosse, Claudia, Cesare E. M. Gruber, Martina Rueca, Chiara Taibi, Mauro Zaccarelli, Elisabetta Grilli, Marzia Montalbano, Maria R. Capobianchi, Andrea Antinori, Gianpiero D’Offizi, and et al. 2021. "Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs" Viruses 13, no. 6: 1151. https://doi.org/10.3390/v13061151

Minosse, C., Gruber, C. E. M., Rueca, M., Taibi, C., Zaccarelli, M., Grilli, E., Montalbano, M., Capobianchi, M. R., Antinori, A., D’Offizi, G., McPhee, F., & Garbuglia, A. R. (2021). Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs. Viruses, 13(6), 1151. https://doi.org/10.3390/v13061151